As an organization that endeavors to improve healthcare for all, every choice we make is driven by our mission: to better serve patients by accelerating and innovating health care through approaches that challenge the status quo of science and care.
The culmination of our daily efforts guides our long-term vision: to improve human health for all through personalized medicine by bridging the gap between research and care.
Our core foundational values of integrity, collaboration, transparency, and innovation form the basis of who we hire, how we operate, and everything we believe.
We strive for the best outcomes and our quality policy reflects that: we embrace equity, collaboration, innovation and quality in trial design, conduct, and patient-centric research outcomes.
WHY WE DO WHAT WE DO
A leap in cancer research born from collaboration between scientists and entrepreneurs.
QLHC Leadership
Our company founders had seen it time and again: good ideas and research projects in University settings were often “orphaned” at the end of a research project leaving them with no funds or organizations structure to adequately engage clinical providers leaving valuable IP undeveloped. The kind of IP that could radically change patient care. So, in 2005, we were created as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs to change what cancer research and clinical trials could be.
Working at QLHC
Taking giant leaps to defeat cancer wouldn’t be possible without a world-class team of thinkers from a diverse and unique set of backgrounds who make up our team. Discover all the reasons people love working at QLHC along with our latest open roles.
QLHC Media Relations
For all media related questions and inquiries, please contact Jacqueline Murray.
After years of watching women diagnosed with the disease get the same, drastic treatment of disfiguring surgery or brutal chemotherapy and radiation, Esserman believed doctors not only could but should be able to do better.